🔗 Share this article

A shadow economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Investigational Drug Acquiring Popularity Via Social Media

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where groups with numerous of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Vendors market the substance there before directing customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have cautions that the sale of what is still an unlicensed drug in the UK is worrisome and could lead to individuals administering substances of unknown origin.

Several professionals stated the demand for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for human use under the British medical regulations.

Several content creators try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and customer regulations, risking fines, prosecution or imprisonment.

Platform Response and Content Removal

Based on the social media company, the service has removed violative material and banned associated keywords and search suggestions. The company said it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also found communities with up to nine thousand members selling retatrutide using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, populated with images of weight loss, positive testimonials and step-by-step instructions for preparing or injecting at residence.

After moments of joining one group, a seller posted contact information, where the majority of purchases occur. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about weight, health issues or previous experience.

Product Information and Pricing

Within these communities, posts display black plastic parcels with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20mg. When questioned how long a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for the messaging service stated it actively moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting materials they can’t verify. Although the research behind this drug is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has already seen patients injured by self-injection from unverified suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose patients to potentially significant medical dangers”.